Precision Medicine

The Precision Medicine group focuses on designing and evaluating nanotherapeutics that regulate the immune response to treat a range of conditions, including cancer, cardiovascular and autoimmune diseases.

Nanotechnology for immunotherapy

Nanotechnology can be applied to empower the immune system’s ability to fight disease, by promoting or inhibiting an immune response, by polarizing macrophage function, or by targeting myeloid cell dynamics. The innovation cascade involves developing biocompatible nanoimmunotherapeutics from natural molecular building blocks and comprises an innovative translational workflow, involving noninvasive imaging for testing on small and large animal disease models.

Meet some of our Researchers

Full Professor
(Part-time)

Willem Mulder

Associate Professor

Roy van der Meel

Recent Publications

Our most recent peer reviewed publications

Contact